http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022230723-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4c3e182c0c7bc69e566750a7c5d0bdda |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-0001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-3553 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H04L9-3213 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H04L63-0853 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H40-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H40-67 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-13 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H40-67 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H20-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H20-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/H04L9-40 |
| filingDate | 2019-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04bdef0fcd6df2517b6ee4589639b28f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d54c4afbdbc861ca9ecdbe68b28629c3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7242db50ad752d9bf2454b872008eac http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15b3725b78f85fe5c2e895a50e753067 |
| publicationDate | 2022-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2022230723-A1 |
| titleOfInvention | Electronically Supervised Administration of a Pharmaceutical Composition |
| abstract | A system for electronically supervised administration of a pharmaceutical composition, that comprises an authorised entity node (100, 200) for an authorised entity, a mobile device (300) of a patient, and a medical device (400) adapted to administer the pharmaceutical composition, wherein the authorised entity node (100, 200) is adapted, when operated by the authorised entity, to generate data corresponding to an administration scheme (11) and an authorisation token (12) for assigning to a patient's mobile device (300), and to send the data corresponding to an administration scheme (11) and authorisation token (12) to the patient's mobile device (300). The mobile device (300) is adapted to send to the authorised entity node (100, 200) the data corresponding to the mobile device (300) and medical device (400), and to receive the authorisation token (12) assigned to a patient's mobile device (300) and send to the medical device (400) the data corresponding to the administration scheme (11) in response to receiving the authorisation token (12) assigned to a patients mobile device (300). The medical device (400) is provided with a controlled blocking means (403) for blocking administration of the pharmaceutical composition, is adapted to determine whether the mobile device (300) with the authorisation token assigned thereto is present and is adapted to control the controlled blocking means (403) so as to allow administration of the pharmaceutical composition only with compliance with the administration scheme (11) received from the mobile device (300) in the presence of the mobile device (300) with the authorisation token (12) assigned thereto. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022301725-A1 |
| priorityDate | 2019-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 95.